Advertisement

Oncology / Hematology General

PSA Screening: More Harm Than Good

Oct 16, 2013

A new analysis presented at the European Cancer Conference 2013 adds fuel to the ongoing debate over whether routine prostate cancer screening reduces prostate cancer mortality. Overall, lead author M...

Updated Breast Cancer Guidelines for HER2 Testing

Oct 16, 2013

A new update to clinical practice guidelines for HER2 testing in breast cancer was published online last week by the American Society of Clinical Oncology and the College of American Pathologists in t...

Researchers Identify a Protein that May Predict Who Will Have Thyroid Cancer Recurrence

Oct 08, 2013

WASHINGTON, DC— Researchers at the National Institutes of Health (NIH), Bethesda, MD, have taken the first steps to determine if a protein, called Programmed Death Ligand 1 (PD-L1), can help to pred...

ACS 2013: A Laparoscopic Approach to Colon Resection

Oct 08, 2013

The Particulars: Among the elderly, research suggests that elective colon resection is associated with poor perioperative outcomes. Using a laparoscopic approach to colon resection in the elderly may ...

Contralateral Prophylactic Mastectomy May Not Significantly Increase Life Expectancy in Women with Early-Stage Breast Cancer

Oct 08, 2013

WASHINGTON, DC—Women with early-stage breast cancer in one breast are increasingly opting to undergo a more aggressive operation to remove both breasts called contralateral prophylactic mastectomy (...

Colon Polyps in Elderly Patients Are More Likely to Develop in Areas Seen Only with Colonoscopy

Oct 08, 2013

WASHINGTON, DC—People over 60 years old are more likely to have precancerous or cancerous polyps develop in a part of the colon that goes unseen by flexible sigmoidoscopy, a common screening test fo...

Enhancing QOL During Radiotherapy for Advanced Cancer

Sep 27, 2013

Cancer patients often experience a reduction in quality of life (QOL) during and after cancer treatment. Many experience pain, nausea, fatigue, sleep, and distress, among others. Family members caring...

Considerations for Dosing of Oral Therapies in Metastatic RCC

Sep 12, 2013

For patients with meta­static renal cell carcinoma (mRCC), oral therapy has improved out­comes and has become a standard of care. When selecting oral therapies for mRCC, an important consideration ...

Guidelines for CT Use in Lung Cancer Screening

Sep 05, 2013

In August 2011, results of the National Lung Screening Trial (NLST) were published in the New England Journal of Medicine. The study found that low-dose CT (LDCT) screening correlated with a reduction...

ICAAC 2013

Sep 04, 2013

New research is being presented at ICAAC 2013, the Interscience Conference on Antimicrobial Agents and Chemotherapy, from September 10-13 in Denver. Meeting Highlights A Look at CDI Trends ...

Functional Outcomes After Treatment for Prostate Cancer

Aug 26, 2013

Studies have shown that patients with localized prostate cancer have favorable long-term overall survival rates and cancer-specific survival regardless of the treatment that is selected. Few prospecti...

Predicting Avoidable 30-Day Readmissions

Aug 07, 2013

Throughout the United States, readmission rates are increasingly being used for benchmarking across hospitals. Some hospital readmissions may be avoidable, which in turn has led to the levying of fina...

Metastatic Renal Cell Carcinoma Therapy: Supporting Patients

Aug 01, 2013

Data from the American Cancer Society estimate that 65,150 new cases of kidney cancer, including renal cell carcinoma (RCC), renal pelvis carcinoma, and Wilms tumor, are expected to be diagnosed in th...

FDA Approves Gilotrif for Late-Stage NSCLC

Jul 12, 2013

The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal g...

Cancer Survivorship Rates Predicted to Soar

Jun 28, 2013

A National Cancer Institute study has found that approximately 13.7 million cancer survivors were living in the United States as of 2012, a figure which is expected to approach 18 million by 2022. Abo...

A Different Approach to Delivering Smoking Cessation

Jun 27, 2013

Although the health benefits of smoking cessation are well documented, only about 6% of smokers successfully quit each year. Quitlines deliver highly effective telephone-based smoking cessation servic...

FDA Approves Xgeva for Giant Cell Tumor of the Bone

Jun 13, 2013

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancero...

Surviving Surgery After Early Stage Breast Cancer

Jun 04, 2013

Among patients with early stage breast cancer, breast-conserving therapy with radiation appears to be associated with a better disease-specific survival (DSS) when compared with mastectomy. A large in...

Standard-Dose Radiation Best for Stage III NSCLC

Jun 04, 2013

A phase III trial in patients with stage III non-small cell lung cancer (NSCLC) concludes that standard dose (SD) radiotherapy (60 Gy) is safer and more effective than high-dose (HD) radiotherapy (74 ...

ASCO 2013: Burnout Among Oncologists

Jun 04, 2013

The Particulars: Many studies have explored burnout among oncologists practicing in the United States, but most of the recent data was released in the early 2000s. Data are also lacking on personal an...